GAL and metabolic dysfunction-associated steatotic liver disease: AEG-1 overexpression leads to NAFLD, a precursor of HCC, and PAMAM-PEG-Gal delivered AEG-1 siRNA protected mice from developing high fat diet (HFD)-induced NAFLD, further establishing the utility of this approach [29].